Encore Medical
This article was originally published in The Gray Sheet
Executive Summary
Tender offer begins for the company's outstanding warrants at an exercise price of $7 and outstanding rights to acquire such warrants at $0.25 per warrant, net to seller. "Encore is making the tender offer to eliminate the potential dilutive effect that would occur if the warrants or rights to the warrants were exercised by the holders thereof on or before March 25, 2001," the firm explains. About 1.2 mil. warrants and 445,220 purchase rights are outstanding. The tender offer will remain open through Dec. 30